208 related articles for article (PubMed ID: 6214261)
1. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.
Kean WF; Lock CJ; Howard-Lock HE; Buchanan WW
Arthritis Rheum; 1982 Aug; 25(8):917-22. PubMed ID: 6214261
[TBL] [Abstract][Full Text] [Related]
2. HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
Dahlqvist SR; Ström H; Bjelle A; Möller E
Clin Rheumatol; 1985 Mar; 4(1):55-61. PubMed ID: 3157529
[TBL] [Abstract][Full Text] [Related]
3. Adverse reactions to D-penicillamine after gold toxicity.
Dodd MJ; Griffiths ID; Thompson M
Br Med J; 1980 Jun; 280(6230):1498-500. PubMed ID: 6770953
[TBL] [Abstract][Full Text] [Related]
4. The toxicity of D-penicillamine in systemic sclerosis.
Steen VD; Blair S; Medsger TA
Ann Intern Med; 1986 May; 104(5):699-705. PubMed ID: 2938530
[TBL] [Abstract][Full Text] [Related]
5. Precipitating autoantibody to a ubiquitous tissue antigen: association with rheumatoid arthritis treated with sodium aurothiomalate or d-penicillamine.
Palosuo T; Kajander A; von Essen R; Milgrom F
Clin Immunol Immunopathol; 1978 Jul; 10(3):355-64. PubMed ID: 97039
[No Abstract] [Full Text] [Related]
6. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
[TBL] [Abstract][Full Text] [Related]
7. Gold vs D-penicillamine double blind study and followup.
Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
[TBL] [Abstract][Full Text] [Related]
8. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine.
Domljan Z; Borso G; Marinković M; Winter Fudurić I; Pucar I; Cikes N
Acta Med Iugosl; 1987; 41(5):363-72. PubMed ID: 3128058
[No Abstract] [Full Text] [Related]
9. Efficacy and toxicity of D-penicillamine for rheumatoid disease in the elderly.
Kean WF; Anastassiades TP; Dwosh IL; Ford PM; Kelly WG; Dok CM
J Am Geriatr Soc; 1982 Feb; 30(2):94-100. PubMed ID: 6460054
[TBL] [Abstract][Full Text] [Related]
10. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
Batlle Gualda E
Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
[No Abstract] [Full Text] [Related]
11. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
[TBL] [Abstract][Full Text] [Related]
12. Sulphasalazine in rheumatoid arthritis: combination therapy with D-penicillamine or sodium aurothiomalate.
Farr M; Kitas G; Bacon PA
Clin Rheumatol; 1988 Jun; 7(2):242-8. PubMed ID: 2901303
[TBL] [Abstract][Full Text] [Related]
13. The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis.
Kean WF; Dwosh IL; Anastassiades TP; Ford PM; Kelly HG
Arthritis Rheum; 1980 Feb; 23(2):158-64. PubMed ID: 7362666
[TBL] [Abstract][Full Text] [Related]
14. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
Munthe E; Kåss E
J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435
[TBL] [Abstract][Full Text] [Related]
15. Influence of previous gold toxicity on subsequent development of penicillamine toxicity.
Smith PJ; Swinburn WR; Swinson DR; Stewart IM
Br Med J (Clin Res Ed); 1982 Aug 28-Sep 4; 285(6342):595-6. PubMed ID: 6218857
[TBL] [Abstract][Full Text] [Related]
16. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
Pachoula-Papasteriades C; Boki K; Varla-Leftherioti M; Kappos-Rigatou I; Fostiropoulos G; Economidou J
Dis Markers; 1986 Jun; 4(1-2):35-41. PubMed ID: 3133153
[TBL] [Abstract][Full Text] [Related]
17. Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.
Huskisson EC; Gibson TJ; Balme HW; Berry H; Burry HC; Grahame R; Hart FD; Henderson DR; Wojtulewski JA
Ann Rheum Dis; 1974 Nov; 33(6):532-5. PubMed ID: 4216306
[No Abstract] [Full Text] [Related]
18. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
[TBL] [Abstract][Full Text] [Related]
19. Sequential gold and penicillamine therapy in rheumatoid arthritis.
Halla JT; Cassady J; Hardin JG
Am J Med; 1982 Mar; 72(3):423-6. PubMed ID: 6174045
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of rheumatoid arthritis with gold salts].
Aranguena L; Hinojosa W; Chincaro C; Portugal J; Barrenechea O
Rev Clin Esp; 1984 Jun 15-30; 173(5-6):305-8. PubMed ID: 6238373
[No Abstract] [Full Text] [Related]
[Next] [New Search]
